trimethoprim(20mg/Tb) sulfadiazine(100mg/Tb) - søkeresultat

USA - engelsk - NLM (National Library of Medicine)

trimethoprim tablet

golden state medical supply, inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of trimethoprim tablets and other antibacterial drugs, trimethoprim tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli , proteus mirabilis , klebsiella pneumoniae , enterobacter species, and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and susceptibility tests should be performed to determine the susceptibility of the bacter

USA - engelsk - NLM (National Library of Medicine)

uniprim- trimethoprim and sulfadiazine powder

neogen corporation - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x), sulfadiazine (unii: 0n7609k889) (sulfadiazine - unii:0n7609k889) - uniprim powder for horses is indicated in horses where potent systemic antibacterial action against sensitive organisms is required. uniprim powder for horses is indicated where control of bacterial infections is required during treatment of: uniprim powder for horses is well tolerated by foals. trimethoprim and sulfadiazine should not be used in horses showing marked liver parenchymal damage, blood dyscrasias, or in those with history of sulfonamide sensitivity.

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

trivetrin injection

USA - engelsk - NLM (National Library of Medicine)

primsol- trimethoprim hydrochloride solution

fsc laboratories, inc - trimethoprim hydrochloride (unii: 9xe000ou9b) (trimethoprim - unii:an164j8y0x) - trimethoprim 50 mg in 5 ml - primsol solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below. for the treatment of acute otitis media due to susceptible strains of streptococcus pneumoniae and haemophilus influenzae. note: moraxella catarrhalis isolates were found consistently resistant to trimethoprim in vitro. therefore, when infection with moraxella catarrhalis is suspected, the use of alternative antimicrobial agents should be considered. primsol is not indicated for prophylactic or prolonged administration in otitis media at any age. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli, proteus mirabilis, klebsiella pneumoniae, enterobacter species and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and susceptibility tests should be performed to determine the susceptibility of the bacteria to trimethoprim

USA - engelsk - NLM (National Library of Medicine)

primsol- trimethoprim hydrochloride solution

allegis holdings, llc - trimethoprim hydrochloride (unii: 9xe000ou9b) (trimethoprim - unii:an164j8y0x) - trimethoprim 50 mg in 5 ml - primsol solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below. for the treatment of acute otitis media due to susceptible strains of streptococcus pneumoniae and haemophilus influenzae . note: moraxella catarrhalis isolates were found consistently resistant to trimethoprim in vitro . therefore, when infection with moraxella catarrhalis is suspected, the use of alternative antimicrobial agents should be considered. primsol is not indicated for prophylactic or prolonged administration in otitis media at any age. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli, proteus mirabilis, klebsiella pneumoniae, enterobacter species and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and s